This forum is for questions about medical issues and research aspects of
Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new
Hepatitis Social/Living with Hepatitis forum
Best wishes and let us know!
Deb
My personal opinion is that, absent any contraindications, it's better to initiate HCV treatment early post transplant. His doses are much better than mine were when I first started treatment. I started about 6 or 8 weeks after my transplant with low ribavirin dose and a standard interferon dose (there wasn't Peg back then). That treatment did normalize my liver enzymes and after 1 year I stopped but I did not clear. About 6 months later I started Peg-Intron and 800 mg ribavirin. I cleared late - maybe 6 months - and stopped at 52 weeks and relapsed immediately. About 6 weeks later I started Pegasys 180 mcg and 1000 mg ribavirin. I was undetectable by week 12 (probably a week or two sooner but I didn't test until week 12) and treated for 73 weeks and achieved SVR. My starting VL for this last treatment was 3.65 million IU/ml but 6 weeks previously it was 6.8 million IU/ml so VL can fluctuate significantly in a short period of time. I was also diabetic and had received at least 2 bolus intravenous injections of Solu-Medrol for organ rejection episodes. These rejections did not occur during treatment however.The diabetes and bolus treatments are considered negative predictors for SVR and yet I made it. I say this because I suspect that his viral load is worrying you. While it is not a positive predictor I do not think it in insurmountable.
I do think you have to insist on a 4 week VL test because being undetectable at 4 weeks is highly predictive of SVR and may also influence his doctors' advice regarding duration of treatment. I have not heard of patients - transplant or non-transplants- treating with Peg and Riba for a year and doing another year of monotherapy with Peg. Perhaps it is a new approach but I would want to know more about it. I think that extending treatment is often a big advantage depending on when the patient becomes undetectable and that it why I would want the 4 week VL. I also think that depending on the 4 week result more testing may be appropriate before the standard week 12 VL test. It is helpful to know, as close as possible, the week at which he becomes undetectable.
I required Epogen to boost my RBCs and hemoglobin during my treatments. My platelet count became quite low (low 20,000s) but I was allowed to continue treatment. You may also see (if you get copies of his labs and I suggest that you do) some irregularities noted regarding his platelets and I don't think this is reason for concern. I saw on my labs "One giant platelet observed" but my team wasn't concerned and now my platelet counts are normal ad no abnormal morphology is seen.
If there is anything else I might be able to help you with don't hesitate to ask me. You can PM me if that would be better for you. I can't say I will be able to help but I will try.
Good luck,
Mike
I do hope you take Mike up on his offer, he has a huge amount of knowledge, especially concerning transplant, Also if you do not understand all the terminology he will patiently answer!
Good luck
Like Mike, I also am not familiar with Peg only therapy following SOC in transplant patients, especially if one responds reasonably well -- UND by week 4 or 12. You might ask your medical team for studies/rationale and seek a second opinion if you still have doubts. And as suggested, get a very sensitive week 4 viral load test to give you a better idea on response which can then better help predict SVR.
-- Jim
We know now that the 4 week test is very important and your Husband has the right to be tested at that point. If they are resistant to test his VL at 4 weeks I would not be as comfortable as I would if they agreed that there is value to the test. If by chance you are told that a 4 week VL is not as valuable in the transplant recipient population as it is in the general population (and I am merely trying to anticipate any possible negative response - I have no reason to assume that will be their response) I would demand to see evidence of that premise. I do not believe there is any basis for any distinction in the transplant population. It is a valuable test and he should definitely get one. Again, I wish you good luck. Stay strong and be a strong advocate. That can really be important.
Mike
Mike